These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11762576)

  • 1. Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder.
    Vitiello B
    CMAJ; 2001 Nov; 165(11):1505-6. PubMed ID: 11762576
    [No Abstract]   [Full Text] [Related]  

  • 2. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C; Huissoud T; Dubois-Arber F
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.
    New South Wales Department of Health
    N S W Public Health Bull; 2004; 15 Suppl 3():1-55. PubMed ID: 15448720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of methylphenidate among children in Iceland 1989-2006].
    Zoëga H; Baldursson G; Halldórsson M
    Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of outpatient prescription drug utilization in US children, 2002-2010.
    Chai G; Governale L; McMahon AW; Trinidad JP; Staffa J; Murphy D
    Pediatrics; 2012 Jul; 130(1):23-31. PubMed ID: 22711728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
    Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
    Bonati M; Impicciatore P; Pandolfini C
    BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate: prescribing patterns in a South African primary care patient population.
    Truter I
    J Clin Pharm Ther; 2005 Feb; 30(1):59-63. PubMed ID: 15659004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003].
    Donker GA; Groenhof F; van der Veen WJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1742-7. PubMed ID: 16114292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit-hyperactivity disorder.
    Diller LH
    N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
    [No Abstract]   [Full Text] [Related]  

  • 15. Nurse-delivered and doctor-delivered care in an attention deficit hyperactivity disorder follow-up clinic: a comparative study using propensity score matching.
    Foreman DM; Morton S
    J Adv Nurs; 2011 Jun; 67(6):1341-8. PubMed ID: 21375572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 17. Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial.
    Moshe K; Karni A; Tirosh E
    Atten Defic Hyperact Disord; 2012 Sep; 4(3):153-8. PubMed ID: 22622628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness outcomes in attention-deficit/hyperactivity disorder.
    Weiss MD; Gadow K; Wasdell MB
    J Clin Psychiatry; 2006; 67 Suppl 8():38-45. PubMed ID: 16961429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.